Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2019 | 1 |
2021 | 1 |
2022 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Targeted Therapeutic Options and Future Perspectives for HER2-Positive Breast Cancer.
Cancers (Basel). 2022 Jul 6;14(14):3305. doi: 10.3390/cancers14143305.
Cancers (Basel). 2022.
PMID: 35884366
Free PMC article.
Review.
Lights and Shadows in Immuno-Oncology Drug Development.
Bergamino Sirvén M, Pernas S, Cheang MCU.
Bergamino Sirvén M, et al.
Cancers (Basel). 2021 Feb 9;13(4):691. doi: 10.3390/cancers13040691.
Cancers (Basel). 2021.
PMID: 33572060
Free PMC article.
Item in Clipboard
Real-world efficacy and safety of eribulin in advanced and pretreated HER2-negative breast cancer in a Spanish comprehensive cancer center.
Sirvén MB, Fernández-Ortega A, Stradella A, Morilla I, Falo C, Vázquez S, Castany R, Villanueva R, Recalde S, Pérez VN, Gil-Gil M, Pernas S.
Sirvén MB, et al.
BMC Pharmacol Toxicol. 2019 Nov 21;20(1):68. doi: 10.1186/s40360-019-0367-x.
BMC Pharmacol Toxicol. 2019.
PMID: 31753013
Free PMC article.
Item in Clipboard
Cite
Cite